- Home
- TRIP vs BCRX Comparison
TRIP vs BCRX Comparison
Compare TRIP & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRIP
- BCRX
- Stock Information
- Founded
- TRIP 2000
- BCRX 1986
- Country
- TRIP United States
- BCRX United States
- Employees
- TRIP N/A
- BCRX N/A
- Industry
- TRIP Computer Software: Programming Data Processing
- BCRX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TRIP Technology
- BCRX Health Care
- Exchange
- TRIP Nasdaq
- BCRX Nasdaq
- Market Cap
- TRIP 2.1B
- BCRX 1.9B
- IPO Year
- TRIP 2011
- BCRX 1994
- Fundamental
- Price
- TRIP $15.11
- BCRX $9.21
- Analyst Decision
- TRIP Hold
- BCRX Buy
- Analyst Count
- TRIP 14
- BCRX 6
- Target Price
- TRIP $17.79
- BCRX $15.50
- AVG Volume (30 Days)
- TRIP 2.6M
- BCRX 3.1M
- Earning Date
- TRIP 02-20-2025
- BCRX 02-24-2025
- Dividend Yield
- TRIP N/A
- BCRX N/A
- EPS Growth
- TRIP N/A
- BCRX N/A
- EPS
- TRIP 0.04
- BCRX N/A
- Revenue
- TRIP $1,835,000,000.00
- BCRX $412,579,000.00
- Revenue This Year
- TRIP $7.47
- BCRX $38.44
- Revenue Next Year
- TRIP $7.76
- BCRX $21.23
- P/E Ratio
- TRIP $423.67
- BCRX N/A
- Revenue Growth
- TRIP 2.63
- BCRX 29.92
- 52 Week Low
- TRIP $12.93
- BCRX $4.03
- 52 Week High
- TRIP $28.76
- BCRX $9.50
- Technical
- Relative Strength Index (RSI)
- TRIP 33.00
- BCRX 65.48
- Support Level
- TRIP $17.13
- BCRX $8.63
- Resistance Level
- TRIP $18.09
- BCRX $9.00
- Average True Range (ATR)
- TRIP 0.72
- BCRX 0.36
- MACD
- TRIP -0.33
- BCRX 0.07
- Stochastic Oscillator
- TRIP 5.08
- BCRX 85.20
About TRIP TripAdvisor Inc.
Tripadvisor is the world's leading travel metasearch company. Its platform offers 1 billion reviews and information on about 8 million accommodations, restaurants, experiences, airlines, and cruises. In 2023, 58% of revenue came from the company's core Brand Tripadvisor segment, which includes hotel revenue generated through advertising on its metasearch platform. Viator, its experiences brand, was 41% of sales in 2023, and TheFork, its dining brand, represented 9% of revenue (about 8% of sales were intersegment, which are eliminated from consolidated revenue).
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.